Together Pharma Ltd (TLV:TGTR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 422.00
-1.00 (-0.24%)
Apr 24, 2025, 5:09 PM IDT
Together Pharma Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | -1.17 | -4.32 | -33.52 | -13.78 | 7.15 | Upgrade
|
| Depreciation & Amortization | 6.83 | 6.51 | 6 | 5.48 | 4.24 | Upgrade
|
| Other Amortization | 3.71 | 17.34 | 14.3 | 12.25 | 9.47 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | -0 | 0.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -0.22 | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0.47 | 0 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 1.45 | 4.09 | Upgrade
|
| Other Operating Activities | -3.22 | 4.59 | -0.95 | -13.36 | -3.58 | Upgrade
|
| Change in Accounts Receivable | -4.36 | -4.28 | -7.44 | 0.42 | -1.34 | Upgrade
|
| Change in Inventory | -0.67 | -10.5 | 3.4 | -9.8 | -33.18 | Upgrade
|
| Change in Accounts Payable | 7.17 | 4.41 | 2.96 | -1.15 | 2.89 | Upgrade
|
| Change in Other Net Operating Assets | -5.45 | 0.82 | 1.51 | -0.16 | 0.5 | Upgrade
|
| Operating Cash Flow | 2.85 | 14.83 | -13.73 | -18.64 | -9.7 | Upgrade
|
| Operating Cash Flow Growth | -80.79% | - | - | - | - | Upgrade
|
| Capital Expenditures | -1.48 | -0.87 | -0.33 | -1.53 | -13.75 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | 0.12 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.16 | -0.15 | -0.41 | -0.1 | -5.6 | Upgrade
|
| Investment in Securities | 0.45 | - | - | - | - | Upgrade
|
| Other Investing Activities | -0.2 | -0.6 | 33.79 | -27.23 | -8.66 | Upgrade
|
| Investing Cash Flow | -1.39 | -1.62 | 33.05 | -28.85 | -27.9 | Upgrade
|
| Long-Term Debt Issued | 100.74 | 78.06 | 50.35 | 38.92 | 37.34 | Upgrade
|
| Total Debt Issued | 100.74 | 78.06 | 50.35 | 38.92 | 37.34 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | -0.04 | Upgrade
|
| Long-Term Debt Repaid | -97.58 | -92.28 | -80.22 | -11.84 | -6.36 | Upgrade
|
| Total Debt Repaid | -97.58 | -92.28 | -80.22 | -11.84 | -6.39 | Upgrade
|
| Net Debt Issued (Repaid) | 3.16 | -14.22 | -29.87 | 27.09 | 30.94 | Upgrade
|
| Issuance of Common Stock | 0.21 | - | 11.53 | 24.73 | 10.08 | Upgrade
|
| Other Financing Activities | - | -0.7 | -0.8 | -2.97 | -0.8 | Upgrade
|
| Financing Cash Flow | 3.37 | -14.92 | -19.14 | 48.84 | 40.23 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0 | 0.03 | -0.01 | -0.01 | Upgrade
|
| Net Cash Flow | 4.85 | -1.7 | 0.2 | 1.34 | 2.62 | Upgrade
|
| Free Cash Flow | 1.37 | 13.97 | -14.07 | -20.17 | -23.46 | Upgrade
|
| Free Cash Flow Growth | -90.16% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 1.43% | 15.35% | -45.04% | -167.75% | -208.99% | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 1.59 | -1.73 | -2.94 | -4.07 | Upgrade
|
| Cash Interest Paid | 4.87 | 4.44 | 2.23 | 2.74 | 1.08 | Upgrade
|
| Levered Free Cash Flow | 2.55 | 16.46 | 29.15 | -38.12 | -30.36 | Upgrade
|
| Unlevered Free Cash Flow | 4.76 | 11.36 | 25.6 | -41.12 | -32.42 | Upgrade
|
| Change in Net Working Capital | 2.48 | 7.94 | -32.7 | 39.26 | 31.79 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.